World Health Organization site
Skip Navigation Links

Please fill this short user satisfaction survey


Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 20 August 2018
Main ID:  ChiCTR1800017560
Date of registration: 2018-08-04
Prospective Registration: Yes
Primary sponsor: the Second Affiliated Hospital, Xi'an Jiaotong University
Public title: Association of serum D-dimer and PDF with the BP severity
Scientific title: Association of serum D-dimer and PDF with the BP severity
Date of first enrolment: 2018-08-31
Target sample size: Target condition:160;Difficult condition:0
Recruitment status: Pending
URL:  http://www.chictr.org.cn/showproj.aspx?proj=29364
Study type:  Diagnostic test
Study design:  Diagnostic test for accuracy  
Phase:  Diagnostic New Technique Clincal Study
Countries of recruitment
China
Contacts
Name: Xia Yumin   
Address:  157 Xiwu Road, Xincheng District, Xi'an, Shaanxi, China
Telephone: +86 15619371713
Email: xiayumin1202@163.com
Affiliation:  the Second Affiliated Hospital, Xi'an Jiaotong University
Name: Liu Yale   
Address:  157 Xiwu Road, Xincheng District, Xi'an, Shaanxi, China
Telephone: +86 18209261277
Email: liuyale114@163.com
Affiliation:  the Second Affiliated Hospital, Xi'an Jiaotong University
Key inclusion & exclusion criteria
Inclusion criteria: 1. Aged 18-90 years old male and female;
2. BP was diagnosed based on clinic and pathology;
3. coagulation six indices were conducted after admission;
4. Informed admission consent was signed when they admitted.

Exclusion criteria: Patients with cardiopulmonary and peripheral vascular diseases, acute and chronic inflammation, trauma, pregnancy and other malignant tumors that affect the function of the coagulation system.

Age minimum: 18
Age maximum: 90
Gender: Both
Health Condition(s) or Problem(s) studied
Bullous pemphigoid
Intervention(s)
Gold Standard:Clinical outcome;Index test:D-dimer, FDP, anti-BP180 IgG;
Primary Outcome(s)
D-dimer, FDP, anti-BP180 IgG;SPE, SEN, ACC, AUC of ROC;
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
National natural Fundation
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 03/03/2015
Contact:
Yang Dechang
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history Please fill this short user satisfaction survey